Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: A randomized pilot trial
- 1 October 2014
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 148 (4) , 1647-1655
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Fibrinogen concentrate for management of bleedingJournal of Thrombosis and Haemostasis, 2011
- Transfusion Requirements After Cardiac SurgeryJAMA, 2010
- Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgeryBritish Journal of Anaesthesia, 2010
- Fibrinogen concentrate – a potential universal hemostatic agentExpert Opinion on Biological Therapy, 2009
- Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgeryThrombosis and Haemostasis, 2009
- Plasma fibrinogen level, bleeding, and transfusion after on‐pump coronary artery bypass grafting surgery: a prospective observational studyTransfusion, 2008
- The Ratio of Fibrinogen to Red Cells Transfused Affects Survival in Casualties Receiving Massive Transfusions at an Army Combat Support HospitalJournal of Trauma: Injury, Infection & Critical Care, 2008
- Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infectionHaematologica, 2007
- Guidelines on the management of massive blood lossBritish Journal of Haematology, 2006
- The RACHS-1 risk categories reflect mortality and length of stay in a Danish population of children operated for congenital heart disease☆European Journal of Cardio-Thoracic Surgery, 2005